Outcome of older (>= 70 years) APL patients frontline treated with or without arsenic trioxide-an International Collaborative Study (vol 34, pg 2333, 2020)

Autor: Kayser S, Rahme R, Martinez-Cuadron D, Ghiaur G, Thomas X, Sobas M, Guerci-Bresler A, Garrido A, Pigneux A, Gil C, Raffoux E, Tormo M, Vey N, de la Serna J, Salamero O, Lengfelder E, Levis M, Fenaux P, Sanz M, Platzbecker U, Schlenk R, Ades L, Montesinos P

Publikováno v: LEUKEMIA
r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
instname

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::fa3c06a85dd021bf90c3388021653094
https://www.fundanet.incliva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=16358

Outcome of older (>= 70 years) APL patients frontline treated with or without arsenic trioxide-an International Collaborative Study

Autor: Kayser S, Rahme R, Martinez-Cuadron D, Ghiaur G, Thomas X, Sobas M, Guerci-Bresler A, Garrido A, Pigneux A, Gil C, Raffoux E, Tormo M, Vey N, de la Serna J, Salamero O, Lengfelder E, Levis M, Fenaux P, Sanz M, Platzbecker U, Schlenk R, Ades L, Montesinos P

Publikováno v: LEUKEMIA
r-ISABIAL. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica y Sanitaria de Alicante
instname
r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA

Data on outcome in older (>= 70 years) patients with acute promyelocytic leukemia after treatment with arsenic trioxide (ATO) compared with standard chemotherapy (CTX) is scarce. We evaluated 433 patients (median age, 73.4 years) treated either with

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::4afc3aeeb5e88f6b79bcb15ebf1c56e8
https://fundanet.isabial.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=6016

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

High dose ara-C in the treatment of newly diagnosed acute promyelocytic leukemia: long-term results of the German AMLCG.

Autor: Lengfelder, E.¹ eva.lengfelder@umm.de, Haferlach, C.², Saussele, S.¹, Haferlach, T.², Schultheis, B.¹, Schnittger, S.², Ludwig, W.-D.³, Staib, P.⁴, Aul, C.⁵, Grüneisen, A.⁶, Kern, W.², Reichle, A.⁷, Serve, H.⁸, Berdel, W. E.⁸, Braess, J.⁹, Spiekermann, K.⁹, Wörmann, B.¹⁰, Sauerland, M.-C.¹¹, Heinecke, A.¹¹, Hiddemann, W.⁹

Publikováno v: Leukemia (08876924). Dec2009, Vol. 23 Issue 12, p2248-2258. 11p. 4 Charts, 4 Graphs.

Double induction strategy including high dose cytarabine in combination with all-trans retinoic acid: effects in patients with newly diagnosed acute promyelocytic leukemia. German AML Cooperative Group.

Autor: Lengfelder, E., Reichert, A., Schoch, C., Haase, D., Haferlach, T., Löffler, H., Staib, P., Heyll, A., Seifarth, W., Saussele, S., Fonatsch, C., Gassmann, W., Ludwig, W.-D., Hochhaus, A., Beelen, D., Aul, C., Sauerland, M.-C., Heinecke, A., Hehlmann, R., Wörmann, B.

Publikováno v: Leukemia (08876924). Aug2000, Vol. 14 Issue 8, p1362-1370. 9p.